
Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE
@bettykimlab
Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own
ID: 701854419277643776
22-02-2016 19:41:48
1,1K Tweet
1,1K Takipçi
779 Takip Edilen


📢 Read the full paper in Nature Cancer here: rdcu.be/ebeVG Deeply thankful to Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE and @wenjiang_nano for their mentorship and support and all lab members Yifan Wang, PhD , Annette Wu, Kristin Huntoon, @DYLee_BME , Shiyan Dong , Mengyu Chang, Adam Grippin , Yifan


Congrats Benjamin Schrank, MD, PhD on this study showing proof of concept that an antibody-toxin conjugate can be used to facilitate immune recognition of tumors. Very promising approach for the development of new cancer therapies! #endcancer MD Anderson Cancer Center nature.com/articles/s4301…

Thanks Albert Koong, MD PhD for your encouragement along the way. Your mentorship shapes the growth of trainees like myself MD Anderson Cancer Center and beyond


Thank you ASCO for featuring our study: Novel Antibody-Toxin Conjugate Evaluated in Early Study Stay tuned as we work towards bringing this to our patients MD Anderson Cancer Center Benjamin Schrank, MD, PhD Yifan Wang, PhD ascopost.com/news/february-…


Benjamin Schrank, MD, PhD Nature Cancer Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @wenjiang_nano We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing such valuable content. oncodaily.com/blog/benjamin-…

The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate MD Anderson Cancer Center Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to


Why do tumors evade immune detection, even when phagocytosed? - Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE MD Anderson Cancer Center Yifan Wang, PhD @DYLee_BME Annette Wu oncodaily.com/blog/benjamin-… #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound Jacques Lux Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Yifan Wang, PhD U of A College of Medicine Neurosurgery advanced.onlinelibrary.wiley.com/doi/10.1002/ad…

Partners today for #ACLS Saving lives with Benjamin Schrank, MD, PhD MD Anderson Cancer Center




🎉 Excited to share in Nature Rev Immunol a Mark Yarmarkovich NYU Langone Health study that dramatically expands the known repertoire of tumour-specific peptides for #tcelltherapies. Huge thanks to Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE and the Preprint Club - Immunology for the cross-instituional collaboration nature.com/articles/s4157…



Thrilled to share that I’ve joined MD Anderson Cancer Center as an Assistant Professor & Physician-Scientist in Radiation Oncology--and I’m launching my lab! We’re building a research program at the intersection of genome instability, tumor immunology, and therapeutic development -- and

I’ve Joined MD Anderson Cancer Center as an Assistant Professor and Physician-Scientist in Radiation Oncology - Benjamin Schrank, MD, PhD Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE Albert Koong, MD PhD oncodaily.com/blog/benjamin-… #RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc

